Updated Jul 16, 2026
Goldberg Mark Alan is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days.
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2025-07-17 | BPMC | Blueprint Medicines Corp | J — Other acquisition / disposition | 18.3K | — | |
| 2025-07-17 | BPMC | Blueprint Medicines Corp | D — Derivative transaction | 3.9K | — |
Goldberg Mark Alan is a corporate insider — currently tracked as Director. InsiderAlpha tracks every SEC Form 4 filing in real time.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Goldberg Mark Alan profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.